Serological Evidence of Exposure to Onyong-Nyong and Chikungunya Viruses in Febrile Patients of Rural Taita-Taveta County and Urban Kibera Informal Settlement in Nairobi, Kenya.

ELISA Onyong-nyong alphavirus arbovirus chikungunya febrile illness immunofluorescence neutralization seroprevalence

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
13 06 2022
Historique:
received: 13 04 2022
revised: 28 05 2022
accepted: 08 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Several alphaviruses, such as chikungunya (CHIKV) and Onyong-nyong (ONNV), are endemic in Kenya and often cause outbreaks in different parts of the country. We assessed the seroprevalence of alphaviruses in patients with acute febrile illness in two geographically distant areas in Kenya with no previous record of alphavirus outbreaks. Blood samples were collected from febrile patients in health facilities located in the rural Taita-Taveta County in 2016 and urban Kibera informal settlement in Nairobi in 2017 and tested for CHIKV IgG and IgM antibodies using an in-house immunofluorescence assay (IFA) and a commercial ELISA test, respectively. A subset of CHIKV IgG or IgM antibody-positive samples were further analyzed using plaque reduction neutralization tests (PRNT) for CHIKV, ONNV, and Sindbis virus. Out of 537 patients, 4 (0.7%) and 28 (5.2%) had alphavirus IgM and IgG antibodies, respectively, confirmed on PRNT. We show evidence of previous and current exposure to alphaviruses based on serological testing in areas with no recorded history of outbreaks.

Identifiants

pubmed: 35746757
pii: v14061286
doi: 10.3390/v14061286
pmc: PMC9230508
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Virol. 2019 Jul 30;93(16):
pubmed: 31142666
J Gen Virol. 2000 Feb;81(Pt 2):471-9
pubmed: 10644846
PLoS Negl Trop Dis. 2017 Oct 17;11(10):e0005998
pubmed: 29040262
PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006533
pubmed: 30011271
PLoS Negl Trop Dis. 2015 Feb 06;9(2):e0003436
pubmed: 25658762
PLoS One. 2020 Nov 6;15(11):e0241754
pubmed: 33156857
Rev Panam Salud Publica. 2017 Aug 21;41:e62
pubmed: 28902275
PLoS Negl Trop Dis. 2020 Mar 3;14(3):e0008099
pubmed: 32126086
Int J Environ Res Public Health. 2019 Dec 12;16(24):
pubmed: 31842408
Epidemiol Infect. 2006 Aug;134(4):830-6
pubmed: 16371172
Nat Rev Rheumatol. 2012 May 08;8(7):420-9
pubmed: 22565316
Infect Ecol Epidemiol. 2020 Aug 26;10(1):1798096
pubmed: 32944165
Pathog Glob Health. 2018 Jun;112(4):182-194
pubmed: 29806537
J Med Entomol. 2020 Nov 13;57(6):1972-1982
pubmed: 32533693
Vector Borne Zoonotic Dis. 2015 Feb;15(2):124-32
pubmed: 25700043
Insects. 2020 Jun 03;11(6):
pubmed: 32503123
BMC Infect Dis. 2021 Feb 18;21(1):186
pubmed: 33602147
Open Forum Infect Dis. 2019 Jan 03;6(3):ofz001
pubmed: 31660384
J Vector Borne Dis. 2009 Dec;46(4):273-9
pubmed: 19959853
PLoS Med. 2006 Jul;3(7):e263
pubmed: 16700631
Int J Infect Dis. 2020 Feb;91:104-110
pubmed: 31712089
PLoS One. 2017 Feb 9;12(2):e0171989
pubmed: 28182795
Am J Trop Med Hyg. 2019 May;100(5):1249-1257
pubmed: 30860010
Infect Ecol Epidemiol. 2015 Dec 18;5:29853
pubmed: 26689654
Vector Borne Zoonotic Dis. 2020 Dec;20(12):903-909
pubmed: 32845826
Virol J. 2013 May 10;10:140
pubmed: 23663381
Rev Med Virol. 2016 Jul;26(4):221-41
pubmed: 26990827
Pathog Glob Health. 2019 Jul;113(5):209-228
pubmed: 31664886
Clin Infect Dis. 2019 Sep 27;69(8):1353-1359
pubmed: 30561554
Microorganisms. 2020 Aug 01;8(8):
pubmed: 32752150
Pathog Glob Health. 2017 Sep;111(6):271-275
pubmed: 28829253
Acta Trop. 2018 Dec;188:213-224
pubmed: 30195666
PLoS Negl Trop Dis. 2021 Jan 21;15(1):e0009028
pubmed: 33476338
J Gen Virol. 2018 Jun;99(6):761-762
pubmed: 29745869
Insects. 2019 Jun 16;10(6):
pubmed: 31208124
Parasit Vectors. 2019 Oct 2;12(1):463
pubmed: 31578140
Nat Commun. 2021 Nov 18;12(1):6735
pubmed: 34795213
Crit Care Med. 2008 Sep;36(9):2536-41
pubmed: 18679124
Bull World Health Organ. 1970;43(4):539-52
pubmed: 5313066
J Infect Dis. 2016 Dec 15;214(suppl 5):S436-S440
pubmed: 27920169
Virology. 1998 Dec 5;252(1):258-68
pubmed: 9875334
Am J Trop Med Hyg. 2019 Jan;100(1):170-173
pubmed: 30457092
Trans R Soc Trop Med Hyg. 1981;75(2):239-41
pubmed: 6272457
Viruses. 2019 Jan 18;11(1):
pubmed: 30669393
J Virol. 2012 Mar;86(5):2729-38
pubmed: 22190718

Auteurs

Moses Muia Masika (MM)

KAVI Institute of Clinical Research, University of Nairobi, POB 19676, Nairobi 00202, Kenya.
Department of Medical Microbiology, University of Nairobi, POB 19676, Nairobi 00202, Kenya.

Essi M Korhonen (EM)

Department of Virology, University of Helsinki, 00014 Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, 00014 Helsinki, Finland.

Teemu Smura (T)

Department of Virology, University of Helsinki, 00014 Helsinki, Finland.
HUS Diagnostic Center, HUSLAB, Virology and Immunology, Helsinki University Hospital, 00029 Helsinki, Finland.

Ruut Uusitalo (R)

Department of Virology, University of Helsinki, 00014 Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, 00014 Helsinki, Finland.
Department of Geosciences and Geography, University of Helsinki, 00014 Helsinki, Finland.

Joseph Ogola (J)

KAVI Institute of Clinical Research, University of Nairobi, POB 19676, Nairobi 00202, Kenya.
Department of Medical Microbiology, University of Nairobi, POB 19676, Nairobi 00202, Kenya.

Dufton Mwaengo (D)

Department of Medical Microbiology, University of Nairobi, POB 19676, Nairobi 00202, Kenya.

Anne J Jääskeläinen (AJ)

Department of Virology, University of Helsinki, 00014 Helsinki, Finland.
HUS Diagnostic Center, HUSLAB, Virology and Immunology, Helsinki University Hospital, 00029 Helsinki, Finland.

Hussein Alburkat (H)

Department of Virology, University of Helsinki, 00014 Helsinki, Finland.

Yong-Dae Gwon (YD)

Department of Clinical Microbiology, Umeå University, 90185 SE Umeå, Sweden.

Magnus Evander (M)

Department of Clinical Microbiology, Umeå University, 90185 SE Umeå, Sweden.

Omu Anzala (O)

KAVI Institute of Clinical Research, University of Nairobi, POB 19676, Nairobi 00202, Kenya.
Department of Medical Microbiology, University of Nairobi, POB 19676, Nairobi 00202, Kenya.

Olli Vapalahti (O)

Department of Virology, University of Helsinki, 00014 Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, 00014 Helsinki, Finland.
HUS Diagnostic Center, HUSLAB, Virology and Immunology, Helsinki University Hospital, 00029 Helsinki, Finland.

Eili Huhtamo (E)

Department of Virology, University of Helsinki, 00014 Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, 00014 Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH